Suchergebnisse - "Yamshon, Samuel"

PubPharm (17)

1

Safety and Toxicity Profiles of CAR T Cell Therapy in Non-Hodgkin Lymphoma : A Systematic Review and Meta-Analysis

enthalten in: Clinical lymphoma, myeloma & leukemia | 2024

von Yamshon, S. | Gribbin, C. | Alhomoud, M. | +7

2

Efficacy and Toxicity of CD19 Chimeric Antigen Receptor T Cell Therapy for Lymphoma in Solid Organ Transplant Recipients : A Systematic Review and Meta-Analysis

enthalten in: Transplantation and cellular therapy | 2024

von Yamshon, S. | Gribbin, C. | Chen, Z. | +5

3

Deposition of complement components C5b-9 and MASP2 in tissues is not a feature of GVHD and may assist in discriminating GVHD from thrombotic microangiopathy following allogenic transplantation

enthalten in: Bone marrow transplantation | 2023

von Alhomoud, M. | Magro, C. | Seshan, S. | +8

4

Nine-year follow-up of lenalidomide plus rituximab as initial treatment for mantle cell lymphoma

enthalten in: Blood advances | 2023

von Yamshon, S. | Chen, G. | Gribbin, C. | +9

5

Long COVID in Cancer : A Matched Cohort Study of 1-year Mortality and Long COVID Prevalence Among Patients With Cancer Who Survived an Initial Severe SARS-CoV-2 Infection

enthalten in: American journal of clinical oncology | 2023

von Fankuchen, O. | Lau, J. | Rajan, M. | +6

6

Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation

enthalten in: Transplantation and cellular therapy | 2023

von Alhomoud, M. | Chokr, N. | Gomez-Arteaga, A. | +12

7

Real world CAR T cell data in diffuse large B-cell lymphoma : hitting a moving target

enthalten in: Leukemia & lymphoma | 2022

von Yamshon, S. | Jing-Mei, H.

CommentOn: Leuk Lymphoma. 2022 Sep;63(9):2052-2062. - PMID 35422192

8

Are novel agents ready to assume the mantle in the frontline treatment of mantle cell lymphoma?

enthalten in: Clinical advances in hematology & oncology : H&O | 2021

von Yamshon, S. | Martin, P.

9

Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas : Unveiling New Vulnerabilities for Rational Combination Therapies

enthalten in: Frontiers in cell and developmental biology | 2021

von Serganova, I. | Chakraborty, S. | Yamshon, S. | +5

10

COVID-19 Severity and Outcomes in Patients With Cancer : A Matched Cohort Study

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2020

von Brar, G. | Pinheiro, L. | Shusterman, M. | +10

CommentIn: J Clin Oncol. 2021 Mar 20;39(9):1093-1094. - PMID 33497249